

Body contouring has revolutionized the way we think about self-care and aesthetic transformations. It’s more than just a cosmetic procedure—it’s a path to enhanced confidence and self-expression.
Skin cancer care often begins when someone notices a new or changing spot. A clinician examines the area and may recommend a biopsy, in which some or all of the growth is removed for laboratory testing. Appearance alone cannot confirm cancer, so a concerning change should be assessed by a health professional rather than self-diagnosed. Mayo Clinic’s overview of skin cancer diagnosis
If a biopsy confirms cancer, the results help identify its type and guide decisions about whether further tests are needed. Staging tests are not necessary for everyone, since many skin cancers are unlikely to spread. When clinicians do assess the extent of disease, findings help shape an individual treatment plan. The American Cancer Society’s melanoma staging guide explains how staging informs care for melanoma.
Treatment may involve surgery, a topical medicine, or another approach, depending on the cancer type, its location, and the patient’s circumstances. For facial cancers, preserving healthy tissue can also matter to appearance and function. Dr. Thomas W. Loeb’s Manhattan practice provides individualized care in a boutique setting, while treatment recommendations remain grounded in a clinician’s evaluation. Follow-up visits help monitor healing and check for new or recurring concerns.

Early skin cancer may appear as a new spot or a change in an existing mole, freckle, or patch. Watch for a sore that does not heal or repeatedly crusts or bleeds, and for growths that change in size, shape, color, or texture. Some skin cancers do not cause symptoms, so a spot that does not hurt can still deserve attention.
Basal cell carcinoma may look like a pearly or shiny bump, a scar-like patch, or a sore that heals and returns. Squamous cell carcinoma can appear as a rough, scaly patch or a firm, crusted bump. These are examples, not a complete checklist: skin cancer can look different from person to person. A clinician must assess a suspicious spot rather than relying on appearance alone. Mayo Clinic’s overview of skin cancer diagnosis explains how a medical evaluation can lead to testing.
For melanoma, the ABCDE guide highlights warning signs: asymmetry, an irregular border, varied color, diameter larger than about 6 millimeters (roughly a pencil eraser), and evolution, or change over time. These features signal that a spot should be assessed, but they do not confirm cancer. A clinician may need to examine the skin and perform a biopsy to make a diagnosis.
Check your skin regularly in a well-lit room. Use a full-length mirror and a hand mirror to inspect areas you cannot see easily, or ask someone to help. Look over your scalp, face, ears, hands, feet, back, and the spaces between your toes, noting any new or changing spots. Guidance on a full-body skin examination also includes less-visible areas that can be easy to miss.
Contact a dermatologist or another healthcare professional about a new, changing, bleeding, or nonhealing spot. A self-exam can help you notice changes, but it cannot confirm or rule out skin cancer.

A skin cancer evaluation usually starts with a conversation about the spot, when it appeared, and whether it has changed, bled, or caused itching. The clinician also asks about relevant medical history and examines the skin. If you have been tracking changes with a skin self-exam, photos may help show how a spot has evolved.
A dermatologist may examine a suspicious area with a dermatoscope, a magnifying instrument with a light, or take photographs to compare its appearance over time. These tools can help assess a spot, but appearance alone cannot confirm cancer.
A biopsy is generally needed to confirm suspected skin cancer. The clinician removes some or all of the growth, usually after numbing the area with local anesthetic. A pathologist then examines the tissue under a microscope to determine whether cancer cells are present and, if so, identify the cancer type.
The biopsy method depends on the lesion’s size, location, and appearance. It may remove only a sample or the entire suspicious area. If a spot is new, changing, bleeding, or not healing, arrange an evaluation with a healthcare professional rather than relying on visual checks alone.

After a biopsy confirms skin cancer, doctors assess how far it has grown and whether it has spread. The process helps guide treatment, but the staging approach depends on the cancer type and location.
Doctors consider the tumor’s size and depth, whether it has grown into nearby tissue, and whether cancer is present in nearby lymph nodes or distant parts of the body. Examination and biopsy findings contribute to this assessment. Many basal cell carcinomas do not need formal staging because they are unlikely to spread, while melanoma and some squamous cell cancers may require a closer assessment. Mayo Clinic’s overview of skin cancer staging explains why further tests are not needed in every case.
When findings raise concern about spread, clinicians may consider imaging, such as CT or MRI scans, or a biopsy of a sentinel lymph node, the first node cancer is most likely to reach. These tests are selected based on the suspected cancer and the clinical findings, not as a routine step for everyone.
For some cancers, doctors use the TNM system: T describes the primary tumor, N records nearby lymph node involvement, and M describes distant metastasis. The categories are combined to determine an overall stage. Melanoma staging uses this system, though its details differ from those used for other cancers. The American Cancer Society’s melanoma staging guide outlines how these findings help doctors plan care and discuss the diagnosis.
For skin cancers on the face, staging is only one part of treatment planning. At Dr. Loeb’s practice, Dr. Thomas W. Loeb’s practice focuses on facial aesthetic procedures and individualized planning, making preservation of facial appearance and function relevant to discussions about care. Patients can ask their treating clinician to explain what their stage means and how the findings affect their options.
Skin cancer is not a single disease: basal cell carcinoma, squamous cell carcinoma, and melanoma can behave differently. Their typical patterns help doctors assess risk, but no type follows exactly the same course in every person.
Basal cell carcinoma rarely spreads to distant parts of the body, yet an untreated tumor can grow into and damage nearby tissue. Squamous cell carcinoma can invade deeper skin and sometimes spread to lymph nodes, though this is uncommon. Melanoma is generally the most serious of these cancers because it can spread to distant organs.
The individual tumor matters as much as its name. Size, location, depth, and stage can all shape the outlook and treatment plan, so a broad comparison cannot predict what will happen in a particular case. The American Cancer Society’s melanoma staging guide explains how doctors assess melanoma’s extent.
For skin cancers on the face, treatment planning may also consider how to remove the tumor while preserving healthy tissue. At Dr. Loeb’s practice, Dr. Thomas W. Loeb’s Manhattan practice focuses on individualized facial procedures and natural-looking results, a relevant consideration when discussing care in a visible area.
A spot that persists, changes, bleeds, or does not heal should be assessed by a qualified medical professional rather than judged by appearance alone. The Mayo Clinic’s skin cancer diagnosis guidance describes how evaluation and biopsy can help establish what a suspicious growth is.
What treatments are available for skin cancer, and how is the right option chosen? The plan depends on the cancer’s type, size, location, and stage, along with the patient’s health and circumstances. A dermatologist or cancer specialist can explain which approaches fit the diagnosis and discuss their benefits and risks. Skin cancer treatment options vary by case.
Surgery is a common approach. Standard excision removes the cancer along with some surrounding tissue. In Mohs surgery, the surgeon removes thin layers and examines each under a microscope, continuing until no cancer cells remain. This method can help preserve more healthy skin, which may matter when a tumor is near the eyes, nose, or lips. For selected lesions, curettage and electrodessication scrapes away the growth and treats its base with an electric needle.
Other options include prescription medicines applied to the skin, photodynamic therapy, and radiation. Chemotherapy, targeted therapy, or immunotherapy may be considered in some cases, particularly when cancer is more extensive or other treatment is needed. These approaches are not interchangeable: suitability depends on the cancer and the individual clinical picture.
The care team weighs complete cancer removal against preserving healthy tissue and function. For facial lesions, that balance can include appearance as well as the area’s function. Dr. Thomas W. Loeb’s Manhattan practice focuses on individualized facial aesthetic procedures, but patients should discuss cancer treatment with the dermatologist or cancer specialist managing their diagnosis. After removal, reconstruction may be considered if the wound affects appearance or function. For more on facial lesions, see skin cancer on the face.
Can skin cancer be treated without surgery? Yes, in some cases. The choice depends on the cancer type, its size, depth and location, and the risk that it could grow or return. A dermatologist generally confirms the diagnosis with a biopsy before discussing treatment.
For selected, superficial basal cell cancers, options may include prescription creams or photodynamic therapy, which uses a light-activated medicine to destroy cancer cells. Radiation may be considered when surgery is unsuitable. These approaches are chosen for specific cases, not as general substitutes for surgery; Mayo Clinic’s overview of skin cancer treatment describes treatment options and how they vary by diagnosis.
Some superficial squamous cell cancers may also be candidates for nonsurgical treatment, but melanoma needs individualized planning with appropriate specialists. Even among basal cell cancers, a treatment suited to a small, shallow lesion may not be appropriate for a deeper, recurrent, or higher-risk tumor. The National Cancer Institute’s patient guide to skin cancer treatment provides further information on treatment approaches.
Surgery can provide an added benefit: the removed tissue can be examined to check whether cancer cells remain. With Mohs surgery, tissue is assessed in layers during the procedure, which can help preserve healthy skin while guiding further removal if needed. At Dr. Loeb’s practice, treatment planning for facial procedures is tailored to each patient’s anatomy and aesthetic goals, making the balance between cancer control and tissue preservation especially relevant for facial lesions.
How successful is treatment for skin cancer, and what affects the prognosis? Many skin cancers are highly treatable when found and treated before they spread. Basal cell and squamous cell cancers are often curable, while melanoma outcomes vary with its stage and whether it has spread. Treatment results depend on the cancer’s type, size, depth, location, extent, and the person’s overall health. No general estimate can predict an individual outcome. Mayo Clinic explains how skin cancer type and extent guide care.
Pathology results help clarify what kind of cancer was found and may describe features that affect treatment planning. Ask a dermatologist or oncology team to explain the results, the outlook for the specific diagnosis, and whether additional care is recommended. For facial lesions, treatment planning may also need to consider the location and surrounding tissue; see more about skin cancer on the face.
Skin cancer can return, and having had one skin cancer can raise the chance of developing another. Follow-up skin examinations help clinicians check the treated area and look for new or changing spots. The schedule depends on the diagnosis, treatment, and personal risk, so ask your clinician how often to return and what changes to report.
How quickly should skin cancer be treated after diagnosis? Follow the timing recommended by your clinician, and do not postpone care without discussing it first. The right schedule depends on the cancer type, stage, location, and your overall health.
Melanoma calls for prompt specialist planning because it can spread. Basal cell and squamous cell cancers are less likely to spread, but they can grow into nearby tissue and cause damage if left untreated. A slower-growing spot still needs appropriate follow-through. Mayo Clinic’s skin cancer treatment guidance explains that treatment choices depend on the individual cancer and may include surgery or other approaches.
Ask your dermatologist or surgeon what treatment is recommended, when it should begin, and what could happen if it is delayed. At Dr. Loeb’s practice, individualized planning is central to care, with treatment tailored to each patient’s goals and circumstances. A clear plan can help you understand the next steps and raise concerns before changing the schedule.
Do not wait for a routine skin check if you notice a new or changing spot that concerns you. Arrange a medical evaluation so a clinician can assess it and advise whether further testing or treatment is needed.
Sun protection remains part of skin cancer care during and after treatment. Cover exposed skin with clothing, wear a hat and sunglasses, and seek shade when practical. Apply sunscreen to exposed areas as directed by your clinician.
Avoid tanning beds and other sources of artificial ultraviolet light. A treated area may need specific care, so follow your clinician’s instructions rather than assuming it can be protected in the same way as unaffected skin. UT Southwestern Medical Center’s guidance on skin cancer diagnosis also recommends covering up and using sunscreen after diagnosis.
Keep the follow-up skin examinations recommended by your care team, since monitoring can help identify a recurrence or a separate new lesion. Tell your clinician about any new or changing spot, or a sore that does not heal. At Dr. Loeb’s practice, individualized planning is central to care, so questions about protecting a treated area or arranging follow-up are best discussed with the clinician managing your treatment.
A changing spot or sore that does not heal deserves professional attention. Appearance alone cannot confirm skin cancer; a clinician can assess the area and, if needed, arrange a biopsy to identify the diagnosis.
Treatment depends on the cancer type and its extent, so ask your healthcare professional what the findings mean, which options fit your situation, and what risks or effects to expect. Mayo Clinic’s skin cancer diagnosis and treatment guide also suggests discussing whether further tests and regular skin exams are appropriate.
Before the appointment, write down your questions and bring a list of medicines and supplements. Agree on a follow-up plan with your care team, including when to return and which changes to report.
Skin cancer care often begins when someone notices a new or changing spot. A clinician examines the area and may recommend a biopsy, in which some or all of the growth is removed for laboratory testing. Appearance alone cannot confirm cancer, so a concerning change should be assessed by a health professional rather than self-diagnosed. Mayo Clinic’s overview of skin cancer diagnosis
If a biopsy confirms cancer, the results help identify its type and guide decisions about whether further tests are needed. Staging tests are not necessary for everyone, since many skin cancers are unlikely to spread. When clinicians do assess the extent of disease, findings help shape an individual treatment plan. The American Cancer Society’s melanoma staging guide explains how staging informs care for melanoma.
Treatment may involve surgery, a topical medicine, or another approach, depending on the cancer type, its location, and the patient’s circumstances. For facial cancers, preserving healthy tissue can also matter to appearance and function. Dr. Thomas W. Loeb’s Manhattan practice provides individualized care in a boutique setting, while treatment recommendations remain grounded in a clinician’s evaluation. Follow-up visits help monitor healing and check for new or recurring concerns.

Early skin cancer may appear as a new spot or a change in an existing mole, freckle, or patch. Watch for a sore that does not heal or repeatedly crusts or bleeds, and for growths that change in size, shape, color, or texture. Some skin cancers do not cause symptoms, so a spot that does not hurt can still deserve attention.
Basal cell carcinoma may look like a pearly or shiny bump, a scar-like patch, or a sore that heals and returns. Squamous cell carcinoma can appear as a rough, scaly patch or a firm, crusted bump. These are examples, not a complete checklist: skin cancer can look different from person to person. A clinician must assess a suspicious spot rather than relying on appearance alone. Mayo Clinic’s overview of skin cancer diagnosis explains how a medical evaluation can lead to testing.
For melanoma, the ABCDE guide highlights warning signs: asymmetry, an irregular border, varied color, diameter larger than about 6 millimeters (roughly a pencil eraser), and evolution, or change over time. These features signal that a spot should be assessed, but they do not confirm cancer. A clinician may need to examine the skin and perform a biopsy to make a diagnosis.
Check your skin regularly in a well-lit room. Use a full-length mirror and a hand mirror to inspect areas you cannot see easily, or ask someone to help. Look over your scalp, face, ears, hands, feet, back, and the spaces between your toes, noting any new or changing spots. Guidance on a full-body skin examination also includes less-visible areas that can be easy to miss.
Contact a dermatologist or another healthcare professional about a new, changing, bleeding, or nonhealing spot. A self-exam can help you notice changes, but it cannot confirm or rule out skin cancer.

A skin cancer evaluation usually starts with a conversation about the spot, when it appeared, and whether it has changed, bled, or caused itching. The clinician also asks about relevant medical history and examines the skin. If you have been tracking changes with a skin self-exam, photos may help show how a spot has evolved.
A dermatologist may examine a suspicious area with a dermatoscope, a magnifying instrument with a light, or take photographs to compare its appearance over time. These tools can help assess a spot, but appearance alone cannot confirm cancer.
A biopsy is generally needed to confirm suspected skin cancer. The clinician removes some or all of the growth, usually after numbing the area with local anesthetic. A pathologist then examines the tissue under a microscope to determine whether cancer cells are present and, if so, identify the cancer type.
The biopsy method depends on the lesion’s size, location, and appearance. It may remove only a sample or the entire suspicious area. If a spot is new, changing, bleeding, or not healing, arrange an evaluation with a healthcare professional rather than relying on visual checks alone.

After a biopsy confirms skin cancer, doctors assess how far it has grown and whether it has spread. The process helps guide treatment, but the staging approach depends on the cancer type and location.
Doctors consider the tumor’s size and depth, whether it has grown into nearby tissue, and whether cancer is present in nearby lymph nodes or distant parts of the body. Examination and biopsy findings contribute to this assessment. Many basal cell carcinomas do not need formal staging because they are unlikely to spread, while melanoma and some squamous cell cancers may require a closer assessment. Mayo Clinic’s overview of skin cancer staging explains why further tests are not needed in every case.
When findings raise concern about spread, clinicians may consider imaging, such as CT or MRI scans, or a biopsy of a sentinel lymph node, the first node cancer is most likely to reach. These tests are selected based on the suspected cancer and the clinical findings, not as a routine step for everyone.
For some cancers, doctors use the TNM system: T describes the primary tumor, N records nearby lymph node involvement, and M describes distant metastasis. The categories are combined to determine an overall stage. Melanoma staging uses this system, though its details differ from those used for other cancers. The American Cancer Society’s melanoma staging guide outlines how these findings help doctors plan care and discuss the diagnosis.
For skin cancers on the face, staging is only one part of treatment planning. At Dr. Loeb’s practice, Dr. Thomas W. Loeb’s practice focuses on facial aesthetic procedures and individualized planning, making preservation of facial appearance and function relevant to discussions about care. Patients can ask their treating clinician to explain what their stage means and how the findings affect their options.
Skin cancer is not a single disease: basal cell carcinoma, squamous cell carcinoma, and melanoma can behave differently. Their typical patterns help doctors assess risk, but no type follows exactly the same course in every person.
Basal cell carcinoma rarely spreads to distant parts of the body, yet an untreated tumor can grow into and damage nearby tissue. Squamous cell carcinoma can invade deeper skin and sometimes spread to lymph nodes, though this is uncommon. Melanoma is generally the most serious of these cancers because it can spread to distant organs.
The individual tumor matters as much as its name. Size, location, depth, and stage can all shape the outlook and treatment plan, so a broad comparison cannot predict what will happen in a particular case. The American Cancer Society’s melanoma staging guide explains how doctors assess melanoma’s extent.
For skin cancers on the face, treatment planning may also consider how to remove the tumor while preserving healthy tissue. At Dr. Loeb’s practice, Dr. Thomas W. Loeb’s Manhattan practice focuses on individualized facial procedures and natural-looking results, a relevant consideration when discussing care in a visible area.
A spot that persists, changes, bleeds, or does not heal should be assessed by a qualified medical professional rather than judged by appearance alone. The Mayo Clinic’s skin cancer diagnosis guidance describes how evaluation and biopsy can help establish what a suspicious growth is.
What treatments are available for skin cancer, and how is the right option chosen? The plan depends on the cancer’s type, size, location, and stage, along with the patient’s health and circumstances. A dermatologist or cancer specialist can explain which approaches fit the diagnosis and discuss their benefits and risks. Skin cancer treatment options vary by case.
Surgery is a common approach. Standard excision removes the cancer along with some surrounding tissue. In Mohs surgery, the surgeon removes thin layers and examines each under a microscope, continuing until no cancer cells remain. This method can help preserve more healthy skin, which may matter when a tumor is near the eyes, nose, or lips. For selected lesions, curettage and electrodessication scrapes away the growth and treats its base with an electric needle.
Other options include prescription medicines applied to the skin, photodynamic therapy, and radiation. Chemotherapy, targeted therapy, or immunotherapy may be considered in some cases, particularly when cancer is more extensive or other treatment is needed. These approaches are not interchangeable: suitability depends on the cancer and the individual clinical picture.
The care team weighs complete cancer removal against preserving healthy tissue and function. For facial lesions, that balance can include appearance as well as the area’s function. Dr. Thomas W. Loeb’s Manhattan practice focuses on individualized facial aesthetic procedures, but patients should discuss cancer treatment with the dermatologist or cancer specialist managing their diagnosis. After removal, reconstruction may be considered if the wound affects appearance or function. For more on facial lesions, see skin cancer on the face.
Can skin cancer be treated without surgery? Yes, in some cases. The choice depends on the cancer type, its size, depth and location, and the risk that it could grow or return. A dermatologist generally confirms the diagnosis with a biopsy before discussing treatment.
For selected, superficial basal cell cancers, options may include prescription creams or photodynamic therapy, which uses a light-activated medicine to destroy cancer cells. Radiation may be considered when surgery is unsuitable. These approaches are chosen for specific cases, not as general substitutes for surgery; Mayo Clinic’s overview of skin cancer treatment describes treatment options and how they vary by diagnosis.
Some superficial squamous cell cancers may also be candidates for nonsurgical treatment, but melanoma needs individualized planning with appropriate specialists. Even among basal cell cancers, a treatment suited to a small, shallow lesion may not be appropriate for a deeper, recurrent, or higher-risk tumor. The National Cancer Institute’s patient guide to skin cancer treatment provides further information on treatment approaches.
Surgery can provide an added benefit: the removed tissue can be examined to check whether cancer cells remain. With Mohs surgery, tissue is assessed in layers during the procedure, which can help preserve healthy skin while guiding further removal if needed. At Dr. Loeb’s practice, treatment planning for facial procedures is tailored to each patient’s anatomy and aesthetic goals, making the balance between cancer control and tissue preservation especially relevant for facial lesions.
How successful is treatment for skin cancer, and what affects the prognosis? Many skin cancers are highly treatable when found and treated before they spread. Basal cell and squamous cell cancers are often curable, while melanoma outcomes vary with its stage and whether it has spread. Treatment results depend on the cancer’s type, size, depth, location, extent, and the person’s overall health. No general estimate can predict an individual outcome. Mayo Clinic explains how skin cancer type and extent guide care.
Pathology results help clarify what kind of cancer was found and may describe features that affect treatment planning. Ask a dermatologist or oncology team to explain the results, the outlook for the specific diagnosis, and whether additional care is recommended. For facial lesions, treatment planning may also need to consider the location and surrounding tissue; see more about skin cancer on the face.
Skin cancer can return, and having had one skin cancer can raise the chance of developing another. Follow-up skin examinations help clinicians check the treated area and look for new or changing spots. The schedule depends on the diagnosis, treatment, and personal risk, so ask your clinician how often to return and what changes to report.
How quickly should skin cancer be treated after diagnosis? Follow the timing recommended by your clinician, and do not postpone care without discussing it first. The right schedule depends on the cancer type, stage, location, and your overall health.
Melanoma calls for prompt specialist planning because it can spread. Basal cell and squamous cell cancers are less likely to spread, but they can grow into nearby tissue and cause damage if left untreated. A slower-growing spot still needs appropriate follow-through. Mayo Clinic’s skin cancer treatment guidance explains that treatment choices depend on the individual cancer and may include surgery or other approaches.
Ask your dermatologist or surgeon what treatment is recommended, when it should begin, and what could happen if it is delayed. At Dr. Loeb’s practice, individualized planning is central to care, with treatment tailored to each patient’s goals and circumstances. A clear plan can help you understand the next steps and raise concerns before changing the schedule.
Do not wait for a routine skin check if you notice a new or changing spot that concerns you. Arrange a medical evaluation so a clinician can assess it and advise whether further testing or treatment is needed.
Sun protection remains part of skin cancer care during and after treatment. Cover exposed skin with clothing, wear a hat and sunglasses, and seek shade when practical. Apply sunscreen to exposed areas as directed by your clinician.
Avoid tanning beds and other sources of artificial ultraviolet light. A treated area may need specific care, so follow your clinician’s instructions rather than assuming it can be protected in the same way as unaffected skin. UT Southwestern Medical Center’s guidance on skin cancer diagnosis also recommends covering up and using sunscreen after diagnosis.
Keep the follow-up skin examinations recommended by your care team, since monitoring can help identify a recurrence or a separate new lesion. Tell your clinician about any new or changing spot, or a sore that does not heal. At Dr. Loeb’s practice, individualized planning is central to care, so questions about protecting a treated area or arranging follow-up are best discussed with the clinician managing your treatment.
A changing spot or sore that does not heal deserves professional attention. Appearance alone cannot confirm skin cancer; a clinician can assess the area and, if needed, arrange a biopsy to identify the diagnosis.
Treatment depends on the cancer type and its extent, so ask your healthcare professional what the findings mean, which options fit your situation, and what risks or effects to expect. Mayo Clinic’s skin cancer diagnosis and treatment guide also suggests discussing whether further tests and regular skin exams are appropriate.
Before the appointment, write down your questions and bring a list of medicines and supplements. Agree on a follow-up plan with your care team, including when to return and which changes to report.
Skin cancer care often begins when someone notices a new or changing spot. A clinician examines the area and may recommend a biopsy, in which some or all of the growth is removed for laboratory testing. Appearance alone cannot confirm cancer, so a concerning change should be assessed by a health professional rather than self-diagnosed. Mayo Clinic’s overview of skin cancer diagnosis
If a biopsy confirms cancer, the results help identify its type and guide decisions about whether further tests are needed. Staging tests are not necessary for everyone, since many skin cancers are unlikely to spread. When clinicians do assess the extent of disease, findings help shape an individual treatment plan. The American Cancer Society’s melanoma staging guide explains how staging informs care for melanoma.
Treatment may involve surgery, a topical medicine, or another approach, depending on the cancer type, its location, and the patient’s circumstances. For facial cancers, preserving healthy tissue can also matter to appearance and function. Dr. Thomas W. Loeb’s Manhattan practice provides individualized care in a boutique setting, while treatment recommendations remain grounded in a clinician’s evaluation. Follow-up visits help monitor healing and check for new or recurring concerns.

Early skin cancer may appear as a new spot or a change in an existing mole, freckle, or patch. Watch for a sore that does not heal or repeatedly crusts or bleeds, and for growths that change in size, shape, color, or texture. Some skin cancers do not cause symptoms, so a spot that does not hurt can still deserve attention.
Basal cell carcinoma may look like a pearly or shiny bump, a scar-like patch, or a sore that heals and returns. Squamous cell carcinoma can appear as a rough, scaly patch or a firm, crusted bump. These are examples, not a complete checklist: skin cancer can look different from person to person. A clinician must assess a suspicious spot rather than relying on appearance alone. Mayo Clinic’s overview of skin cancer diagnosis explains how a medical evaluation can lead to testing.
For melanoma, the ABCDE guide highlights warning signs: asymmetry, an irregular border, varied color, diameter larger than about 6 millimeters (roughly a pencil eraser), and evolution, or change over time. These features signal that a spot should be assessed, but they do not confirm cancer. A clinician may need to examine the skin and perform a biopsy to make a diagnosis.
Check your skin regularly in a well-lit room. Use a full-length mirror and a hand mirror to inspect areas you cannot see easily, or ask someone to help. Look over your scalp, face, ears, hands, feet, back, and the spaces between your toes, noting any new or changing spots. Guidance on a full-body skin examination also includes less-visible areas that can be easy to miss.
Contact a dermatologist or another healthcare professional about a new, changing, bleeding, or nonhealing spot. A self-exam can help you notice changes, but it cannot confirm or rule out skin cancer.

A skin cancer evaluation usually starts with a conversation about the spot, when it appeared, and whether it has changed, bled, or caused itching. The clinician also asks about relevant medical history and examines the skin. If you have been tracking changes with a skin self-exam, photos may help show how a spot has evolved.
A dermatologist may examine a suspicious area with a dermatoscope, a magnifying instrument with a light, or take photographs to compare its appearance over time. These tools can help assess a spot, but appearance alone cannot confirm cancer.
A biopsy is generally needed to confirm suspected skin cancer. The clinician removes some or all of the growth, usually after numbing the area with local anesthetic. A pathologist then examines the tissue under a microscope to determine whether cancer cells are present and, if so, identify the cancer type.
The biopsy method depends on the lesion’s size, location, and appearance. It may remove only a sample or the entire suspicious area. If a spot is new, changing, bleeding, or not healing, arrange an evaluation with a healthcare professional rather than relying on visual checks alone.

After a biopsy confirms skin cancer, doctors assess how far it has grown and whether it has spread. The process helps guide treatment, but the staging approach depends on the cancer type and location.
Doctors consider the tumor’s size and depth, whether it has grown into nearby tissue, and whether cancer is present in nearby lymph nodes or distant parts of the body. Examination and biopsy findings contribute to this assessment. Many basal cell carcinomas do not need formal staging because they are unlikely to spread, while melanoma and some squamous cell cancers may require a closer assessment. Mayo Clinic’s overview of skin cancer staging explains why further tests are not needed in every case.
When findings raise concern about spread, clinicians may consider imaging, such as CT or MRI scans, or a biopsy of a sentinel lymph node, the first node cancer is most likely to reach. These tests are selected based on the suspected cancer and the clinical findings, not as a routine step for everyone.
For some cancers, doctors use the TNM system: T describes the primary tumor, N records nearby lymph node involvement, and M describes distant metastasis. The categories are combined to determine an overall stage. Melanoma staging uses this system, though its details differ from those used for other cancers. The American Cancer Society’s melanoma staging guide outlines how these findings help doctors plan care and discuss the diagnosis.
For skin cancers on the face, staging is only one part of treatment planning. At Dr. Loeb’s practice, Dr. Thomas W. Loeb’s practice focuses on facial aesthetic procedures and individualized planning, making preservation of facial appearance and function relevant to discussions about care. Patients can ask their treating clinician to explain what their stage means and how the findings affect their options.
Skin cancer is not a single disease: basal cell carcinoma, squamous cell carcinoma, and melanoma can behave differently. Their typical patterns help doctors assess risk, but no type follows exactly the same course in every person.
Basal cell carcinoma rarely spreads to distant parts of the body, yet an untreated tumor can grow into and damage nearby tissue. Squamous cell carcinoma can invade deeper skin and sometimes spread to lymph nodes, though this is uncommon. Melanoma is generally the most serious of these cancers because it can spread to distant organs.
The individual tumor matters as much as its name. Size, location, depth, and stage can all shape the outlook and treatment plan, so a broad comparison cannot predict what will happen in a particular case. The American Cancer Society’s melanoma staging guide explains how doctors assess melanoma’s extent.
For skin cancers on the face, treatment planning may also consider how to remove the tumor while preserving healthy tissue. At Dr. Loeb’s practice, Dr. Thomas W. Loeb’s Manhattan practice focuses on individualized facial procedures and natural-looking results, a relevant consideration when discussing care in a visible area.
A spot that persists, changes, bleeds, or does not heal should be assessed by a qualified medical professional rather than judged by appearance alone. The Mayo Clinic’s skin cancer diagnosis guidance describes how evaluation and biopsy can help establish what a suspicious growth is.
What treatments are available for skin cancer, and how is the right option chosen? The plan depends on the cancer’s type, size, location, and stage, along with the patient’s health and circumstances. A dermatologist or cancer specialist can explain which approaches fit the diagnosis and discuss their benefits and risks. Skin cancer treatment options vary by case.
Surgery is a common approach. Standard excision removes the cancer along with some surrounding tissue. In Mohs surgery, the surgeon removes thin layers and examines each under a microscope, continuing until no cancer cells remain. This method can help preserve more healthy skin, which may matter when a tumor is near the eyes, nose, or lips. For selected lesions, curettage and electrodessication scrapes away the growth and treats its base with an electric needle.
Other options include prescription medicines applied to the skin, photodynamic therapy, and radiation. Chemotherapy, targeted therapy, or immunotherapy may be considered in some cases, particularly when cancer is more extensive or other treatment is needed. These approaches are not interchangeable: suitability depends on the cancer and the individual clinical picture.
The care team weighs complete cancer removal against preserving healthy tissue and function. For facial lesions, that balance can include appearance as well as the area’s function. Dr. Thomas W. Loeb’s Manhattan practice focuses on individualized facial aesthetic procedures, but patients should discuss cancer treatment with the dermatologist or cancer specialist managing their diagnosis. After removal, reconstruction may be considered if the wound affects appearance or function. For more on facial lesions, see skin cancer on the face.
Can skin cancer be treated without surgery? Yes, in some cases. The choice depends on the cancer type, its size, depth and location, and the risk that it could grow or return. A dermatologist generally confirms the diagnosis with a biopsy before discussing treatment.
For selected, superficial basal cell cancers, options may include prescription creams or photodynamic therapy, which uses a light-activated medicine to destroy cancer cells. Radiation may be considered when surgery is unsuitable. These approaches are chosen for specific cases, not as general substitutes for surgery; Mayo Clinic’s overview of skin cancer treatment describes treatment options and how they vary by diagnosis.
Some superficial squamous cell cancers may also be candidates for nonsurgical treatment, but melanoma needs individualized planning with appropriate specialists. Even among basal cell cancers, a treatment suited to a small, shallow lesion may not be appropriate for a deeper, recurrent, or higher-risk tumor. The National Cancer Institute’s patient guide to skin cancer treatment provides further information on treatment approaches.
Surgery can provide an added benefit: the removed tissue can be examined to check whether cancer cells remain. With Mohs surgery, tissue is assessed in layers during the procedure, which can help preserve healthy skin while guiding further removal if needed. At Dr. Loeb’s practice, treatment planning for facial procedures is tailored to each patient’s anatomy and aesthetic goals, making the balance between cancer control and tissue preservation especially relevant for facial lesions.
How successful is treatment for skin cancer, and what affects the prognosis? Many skin cancers are highly treatable when found and treated before they spread. Basal cell and squamous cell cancers are often curable, while melanoma outcomes vary with its stage and whether it has spread. Treatment results depend on the cancer’s type, size, depth, location, extent, and the person’s overall health. No general estimate can predict an individual outcome. Mayo Clinic explains how skin cancer type and extent guide care.
Pathology results help clarify what kind of cancer was found and may describe features that affect treatment planning. Ask a dermatologist or oncology team to explain the results, the outlook for the specific diagnosis, and whether additional care is recommended. For facial lesions, treatment planning may also need to consider the location and surrounding tissue; see more about skin cancer on the face.
Skin cancer can return, and having had one skin cancer can raise the chance of developing another. Follow-up skin examinations help clinicians check the treated area and look for new or changing spots. The schedule depends on the diagnosis, treatment, and personal risk, so ask your clinician how often to return and what changes to report.
How quickly should skin cancer be treated after diagnosis? Follow the timing recommended by your clinician, and do not postpone care without discussing it first. The right schedule depends on the cancer type, stage, location, and your overall health.
Melanoma calls for prompt specialist planning because it can spread. Basal cell and squamous cell cancers are less likely to spread, but they can grow into nearby tissue and cause damage if left untreated. A slower-growing spot still needs appropriate follow-through. Mayo Clinic’s skin cancer treatment guidance explains that treatment choices depend on the individual cancer and may include surgery or other approaches.
Ask your dermatologist or surgeon what treatment is recommended, when it should begin, and what could happen if it is delayed. At Dr. Loeb’s practice, individualized planning is central to care, with treatment tailored to each patient’s goals and circumstances. A clear plan can help you understand the next steps and raise concerns before changing the schedule.
Do not wait for a routine skin check if you notice a new or changing spot that concerns you. Arrange a medical evaluation so a clinician can assess it and advise whether further testing or treatment is needed.
Sun protection remains part of skin cancer care during and after treatment. Cover exposed skin with clothing, wear a hat and sunglasses, and seek shade when practical. Apply sunscreen to exposed areas as directed by your clinician.
Avoid tanning beds and other sources of artificial ultraviolet light. A treated area may need specific care, so follow your clinician’s instructions rather than assuming it can be protected in the same way as unaffected skin. UT Southwestern Medical Center’s guidance on skin cancer diagnosis also recommends covering up and using sunscreen after diagnosis.
Keep the follow-up skin examinations recommended by your care team, since monitoring can help identify a recurrence or a separate new lesion. Tell your clinician about any new or changing spot, or a sore that does not heal. At Dr. Loeb’s practice, individualized planning is central to care, so questions about protecting a treated area or arranging follow-up are best discussed with the clinician managing your treatment.
A changing spot or sore that does not heal deserves professional attention. Appearance alone cannot confirm skin cancer; a clinician can assess the area and, if needed, arrange a biopsy to identify the diagnosis.
Treatment depends on the cancer type and its extent, so ask your healthcare professional what the findings mean, which options fit your situation, and what risks or effects to expect. Mayo Clinic’s skin cancer diagnosis and treatment guide also suggests discussing whether further tests and regular skin exams are appropriate.
Before the appointment, write down your questions and bring a list of medicines and supplements. Agree on a follow-up plan with your care team, including when to return and which changes to report.